WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY) Short Interest Update

WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY) was the target of a significant drop in short interest in January. As of January 15th, there was short interest totaling 22,350 shares, a drop of 70.7% from the December 31st total of 76,332 shares. Based on an average trading volume of 122,474 shares, the short-interest ratio is currently 0.2 days. Based on an average trading volume of 122,474 shares, the short-interest ratio is currently 0.2 days.

WuXi Biologics (Cayman) Price Performance

Shares of OTCMKTS:WXXWY opened at $9.51 on Friday. WuXi Biologics has a 12 month low of $4.14 and a 12 month high of $11.21. The stock’s 50 day moving average price is $8.83 and its 200 day moving average price is $8.84.

About WuXi Biologics (Cayman)

WuXi Biologics (Cayman) Inc, trading OTC as WXXWY, is a global contract research, development and manufacturing organization (CDMO) specializing in biologics. Founded as a spin-out from WuXi AppTec and incorporated in the Cayman Islands in 2017, the company offers end-to-end support across the biologics value chain. Its service portfolio encompasses discovery biology, analytical development, process chemistry and large-scale manufacturing for therapeutic proteins and antibodies.

The firm’s core offerings include the development of monoclonal antibodies, recombinant proteins and cell and gene therapy vectors.